...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New trial

"Not that I mind too much, these shares were free anyway."

 free? all it did was take away value from rv & almost a decade later the only person who's made money on this is your leader - ya it's been a beauty ride & so exciting.

Wonder how the folks feel when they look at the current SP who took part in what now appears to be very very high priced PP's?????????

 

Your right about one thing, its working out just fine for donny's retirement 

Share
New Message
Please login to post a reply